Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bronchial hyper-reactivity: recent preclinical developments.

J Morley1, D Wiesinger

  • 1Départment de la recherche préclinique, Sandoz S.A. Bâle, Suisse.

Allergie Et Immunologie
|December 1, 1986
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase transitions in the classical simulability of open quantum systems.

Scientific reports·2023
Same author

Editorial: Loneliness in Old Age: An unaddressed Health Problem.

The journal of nutrition, health & aging·2020
Same author

Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

Designing Drug Trials for Frailty: ICFSR Task Force 2018.

The Journal of frailty & aging·2018
Same author

Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.

The Journal of frailty & aging·2018
Same author

Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US Task Force recommendations.

The journal of nutrition, health & aging·2013
Same journal

[The place of new antihistamines in allergy management. Apropos of desloratadine].

Allergie et immunologie·2003
Same journal

[Skin tests for trophallergens and asthma].

Allergie et immunologie·2003
Same journal

[Prevention of respiratory syncytial virus infection by SYNAGIS (palivizumab)].

Allergie et immunologie·2003
Same journal

[Compendium of specific IgE values according to professional allergists].

Allergie et immunologie·2003
Same journal

[Value of quantitative IgE measurement].

Allergie et immunologie·2003
Same journal

Capillary leakage syndrome: a case report and a review.

Allergie et immunologie·2003
See all related articles

Platelet activating factor (PAF) is implicated in asthma exacerbations, causing airway hyper-reactivity. Understanding PAF

Area of Science:

  • Pulmonary Medicine
  • Allergy and Immunology
  • Pharmacology

Background:

  • Airway hyper-reactivity is a hallmark of asthma, linked to inflammatory responses.
  • IgE-mediated allergic reactions and mast cells were previously considered primary drivers.
  • Existing mast cell stabilizers do not prevent allergen-induced airway hyper-reactivity.

Purpose of the Study:

  • To investigate the role of Platelet Activating Factor (PAF) in asthma pathogenesis.
  • To explore PAF's contribution to airway hyper-reactivity in both allergic and non-allergic conditions.
  • To assess the therapeutic implications of targeting PAF in asthma management.

Main Methods:

  • Review of pre-clinical studies implicating PAF.
  • Analysis of cellular sources of PAF in IgE-dependent reactions (platelets, macrophages, eosinophils).

Related Experiment Videos

  • Evaluation of the effects of established asthma medications and beta-adrenoceptor agonists on PAF-induced hyper-reactivity.

    • Main Results:

    • PAF is implicated as a central mediator in asthma exacerbations.
    • PAF mediates both acute and persistent changes in airway function.
    • Beta-adrenoceptor agonists can intensify PAF-induced airway hyper-reactivity.

    Conclusions:

    • PAF plays a significant role in acute and chronic airway hyper-reactivity in asthma.
    • Targeting PAF may offer new therapeutic strategies for asthma.
    • The findings challenge the sole focus on mast cells and IgE in asthma pathogenesis.